Disruption of Rab11 Activity in a Knock-in Mouse Model of Huntington's Disease

Xueyi Li,Ellen Sapp,Kathryn Chase,Laryssa A. Comer-Tierney,Nicholas Masso,Jonathan Alexander,Patrick Reeves,Kimberly B. Kegel,Antonio Valencia,Miguel Esteves,Neil Aronin,Marian DiFiglia

DOI: https://doi.org/10.1016/j.nbd.2009.08.003

IF: 7.046

2009-01-01

Neurobiology of Disease

Abstract:The Huntington's disease (HD) mutation causes polyglutamine expansion in huntingtin (Htt) and neurodegeneration. Htt interacts with a complex containing Rab11GDP and is involved in activation of Rab11, which functions in endosomal recycling and neurite growth and long-term potentiation. Like other Rab proteins, Rab11GDP undergoes nucleotide exchange to Rab11GTP for its activation. Here we show that striatal membranes of HD140Q/140Q knock-in mice are impaired in supporting conversion of Rab11GDP to Rab11GTP. Dominant negative Rab11 expressed in the striatum and cortex of normal mice caused neuropathology and motor dysfunction, suggesting that a deficiency in Rab11 activity is pathogenic in vivo. Primary cortical neurons from HD140Q/140Q mice were delayed in recycling transferrin receptors back to the plasma membrane. Partial rescue from glutamate-induced cell death occurred in HD neurons expressing dominant active Rab11. We propose a novel mechanism of HD pathogenesis arising from diminished Rab11 activity at recycling endosomes.